A Biomarker Study of ATH434 in Participants With MSA
Trial details
- Registry ID
- NCT05864365
- Drugs studied
- ATH434
TrialRedline tracks 2 clinical trials sponsored by Alterity Therapeutics: 2 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| A Biomarker Study of ATH434 in Participants With MSANCT05864365 | ATH434 | Completed | 2025-02-26Actual |
| Study of ATH434 in Participants with Multiple System AtrophyNCT05109091 | ATH434 dose level 1, ATH434 dose level 2 | Completed | 2024-11-28Actual |
Names as written in the registry records.